Andrew J. Leishman

1.7k total citations
34 papers, 1.3k citations indexed

About

Andrew J. Leishman is a scholar working on Immunology, Oncology and Physiology. According to data from OpenAlex, Andrew J. Leishman has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 15 papers in Oncology and 5 papers in Physiology. Recurrent topics in Andrew J. Leishman's work include Immune Cell Function and Interaction (16 papers), Immune Response and Inflammation (11 papers) and Immunotherapy and Immune Responses (9 papers). Andrew J. Leishman is often cited by papers focused on Immune Cell Function and Interaction (16 papers), Immune Response and Inflammation (11 papers) and Immunotherapy and Immune Responses (9 papers). Andrew J. Leishman collaborates with scholars based in United Kingdom, United States and Japan. Andrew J. Leishman's co-authors include Paul Garside, Mitchell Kronenberg, Hilde Cheroutre, Allan McI. Mowat, Myriam Capone, H. Robson MacDonald, Ed Palmer, Laurent Gapin, Hsiu‐Ching Chang and Antoine Attinger and has published in prestigious journals such as Science, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Andrew J. Leishman

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew J. Leishman United Kingdom 18 966 265 212 122 73 34 1.3k
Márton Keszei United States 18 603 0.6× 154 0.6× 260 1.2× 100 0.8× 118 1.6× 36 1.1k
Thierry Sornasse United States 12 1.1k 1.1× 254 1.0× 210 1.0× 85 0.7× 119 1.6× 30 1.4k
Robert Wadley Australia 10 982 1.0× 250 0.9× 276 1.3× 59 0.5× 79 1.1× 14 1.3k
Dario Magaletti United States 11 853 0.9× 152 0.6× 200 0.9× 67 0.5× 67 0.9× 14 1.1k
Anthony Bonito United States 12 1.5k 1.6× 263 1.0× 207 1.0× 56 0.5× 109 1.5× 12 1.7k
Chiara Buracchi Italy 14 665 0.7× 359 1.4× 248 1.2× 38 0.3× 70 1.0× 25 1.1k
Margot O’Toole United States 14 757 0.8× 149 0.6× 178 0.8× 167 1.4× 185 2.5× 28 1.2k
Isabelle Frémaux France 14 1.0k 1.1× 163 0.6× 304 1.4× 87 0.7× 195 2.7× 21 1.4k
Mahmoud Goodarzi United States 7 904 0.9× 307 1.2× 151 0.7× 153 1.3× 139 1.9× 11 1.3k
Tim Bourne United Kingdom 15 748 0.8× 149 0.6× 274 1.3× 74 0.6× 178 2.4× 24 1.4k

Countries citing papers authored by Andrew J. Leishman

Since Specialization
Citations

This map shows the geographic impact of Andrew J. Leishman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Leishman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Leishman more than expected).

Fields of papers citing papers by Andrew J. Leishman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Leishman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Leishman. The network helps show where Andrew J. Leishman may publish in the future.

Co-authorship network of co-authors of Andrew J. Leishman

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Leishman. A scholar is included among the top collaborators of Andrew J. Leishman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Leishman. Andrew J. Leishman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Mullins, Stefanie, John P. Vasilakos, Katharina Deschler, et al.. (2019). Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies. Journal for ImmunoTherapy of Cancer. 7(1). 244–244. 137 indexed citations
4.
Wilkinson, Robert W. & Andrew J. Leishman. (2018). Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade. Frontiers in Immunology. 9. 1082–1082. 22 indexed citations
5.
Clark, Kristopher, Edward Ainscow, Stuart Thomson, et al.. (2017). CT7001, a Novel Orally Bio-Available CDK7 Inhibitor, Is Highly Active in in-Vitro and in-Vivo Models of AML. Blood. 130. 2645–2645. 15 indexed citations
6.
Dovedi, Simon J., Masashi Murata, Hiroyuki Matsui, et al.. (2012). Intratracheal and oral administration of SM‐276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer. International Journal of Cancer. 132(3). 580–590. 23 indexed citations
7.
Silk, Jonathan D., T. J. Davies, Kathleen F. Nolan, et al.. (2011). Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141+XCR1+ dendritic cells. Gene Therapy. 19(10). 1035–1040. 52 indexed citations
8.
Biffen, Mark, Hiroyuki Matsui, Andrew J. Leishman, et al.. (2011). Biological characterization of a novel class of toll‐like receptor 7 agonists designed to have reduced systemic activity. British Journal of Pharmacology. 166(2). 573–586. 30 indexed citations
9.
Biffen, Mark, Hiroyuki Matsui, Ian Doyle, et al.. (2010). Biological Activity Of Novel TLR7 Ante-drug Agonists For The Treatment Of Allergic Diseases. A4265–A4265. 2 indexed citations
10.
Leishman, Andrew J., Gary P. Sims, Matthew A. Sleeman, & Martin Braddock. (2010). Emerging small molecule and biological therapeutic approaches for the treatment of autoimmunity. Expert Opinion on Investigational Drugs. 20(1). 23–39. 5 indexed citations
11.
Campbell, John D., Martyn Foster, Holger Kanzler, et al.. (2009). CpG-containing immunostimulatory DNA sequences elicit TNF-α–dependent toxicity in rodents but not in humans. Journal of Clinical Investigation. 119(9). 2564–2576. 57 indexed citations
12.
Nickdel, Mohammad B., Paola Conigliaro, Guido Valesini, et al.. (2008). Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis. Annals of the Rheumatic Diseases. 68(6). 1059–1066. 26 indexed citations
13.
Zheng, Ming‐Hua, Dian-na Gu, Martin Braddock, et al.. (2008). CD4+CD25+regulatory T cells: a therapeutic target for liver diseases. Expert Opinion on Therapeutic Targets. 12(3). 313–326. 8 indexed citations
14.
Choo‐Kang, Brian, S Hutchison, Mohammad B. Nickdel, et al.. (2005). TNF-blocking therapies: an alternative mode of action?. Trends in Immunology. 26(10). 518–522. 36 indexed citations
15.
Elewaut, Dirk, Kirsten J. L. Hammond, Hilde De Winter, et al.. (2003). NIK-dependent RelB Activation Defines a Unique Signaling Pathway for the Development of Vα14i NKT Cells. The Journal of Experimental Medicine. 197(12). 1623–1633. 102 indexed citations
16.
Leishman, Andrew J., Laurent Gapin, Myriam Capone, et al.. (2002). Precursors of Functional MHC Class I- or Class II-Restricted CD8αα+ T Cells Are Positively Selected in the Thymus by Agonist Self-Peptides. Immunity. 16(3). 355–364. 167 indexed citations
17.
Smith, Karen, Elaine Thomas, Andrew J. Leishman, et al.. (2000). Th1 and Th2 CD4+ T Cells Provide Help for B Cell Clonal Expansion and Antibody Synthesis in a Similar Manner In Vivo. The Journal of Immunology. 165(6). 3136–3144. 149 indexed citations
18.
Leishman, Andrew J., Paul Garside, & Allan McI. Mowat. (2000). Induction of Oral Tolerance in the Primed Immune System: Influence of Antigen Persistence and Adjuvant Form. Cellular Immunology. 202(2). 71–78. 34 indexed citations
19.
Mowat, Allan McI., Margaret Steel, Andrew J. Leishman, & Paul Garside. (1999). Normal Induction of Oral Tolerance in the Absence of a Functional IL-12-Dependent IFN-γ Signaling Pathway. The Journal of Immunology. 163(9). 4728–4736. 29 indexed citations
20.
Leishman, Andrew J., Paul Garside, & Allan McI. Mowat. (1998). Immunological Consequences of Intervention in Established Immune Responses by Feeding Protein Antigens. Cellular Immunology. 183(2). 137–148. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Márton Keszei Breakdown of academic impact, for papers by Thierry Sornasse Breakdown of academic impact, for papers by Robert Wadley Breakdown of academic impact, for papers by Dario Magaletti Breakdown of academic impact, for papers by Anthony Bonito Breakdown of academic impact, for papers by Chiara Buracchi Breakdown of academic impact, for papers by Margot O’Toole Breakdown of academic impact, for papers by Isabelle Frémaux Breakdown of academic impact, for papers by Mahmoud Goodarzi Breakdown of academic impact, for papers by Tim Bourne
Rankless by CCL
2026